CIBC Asset Management Inc - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC Asset Management Inc ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,098,000
+11.1%
84,766
+11.5%
0.00%0.0%
Q1 2021$988,000
-3.2%
76,046
+2.5%
0.00%
-20.0%
Q4 2020$1,021,000
+3.1%
74,208
+10.3%
0.01%0.0%
Q3 2020$990,000
-4.5%
67,294
+5.0%
0.01%
-16.7%
Q2 2020$1,037,00064,0800.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders